PLA2R1 and membranous glomerulonephritis: Circulating anti-PLA2R antibodies not only contribute to distinguish primary membranous nephropathy from secondary membranous nephropathy in diagnosis but also conduce to monitor the immunological activity degree during the treatment period [19].